Form of S -omeprazole

Details Form of S -omeprazole Form of S -omeprazole

2007-09-11

2010-06-29

Aulakh, Charanjit S (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S273700

Reexamination Certificate

active

07745466

ABSTRACT:
The present invention relates to a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.

REFERENCES:
patent: 4255431 (1981-03-01), Junggren et al.
patent: 4738974 (1988-04-01), Brändström
patent: 4786505 (1988-11-01), Lovgren et al.
patent: 5204118 (1993-04-01), Goldman et al.
patent: 5244891 (1993-09-01), Kaplan et al.
patent: 5417980 (1995-05-01), Goldman et al.
patent: 5530160 (1996-06-01), Nore et al.
patent: 5676884 (1997-10-01), Tiers et al.
patent: 5690960 (1997-11-01), Bengtsson et al.
patent: 5693818 (1997-12-01), von Unge
patent: 5714504 (1998-02-01), Lindberg et al.
patent: 5817338 (1998-10-01), Bergstrand et al.
patent: 5840552 (1998-11-01), Holt et al.
patent: 5877192 (1999-03-01), Lindberg et al.
patent: 5900424 (1999-05-01), Källström et al.
patent: 5948913 (1999-09-01), Yamamoto et al.
patent: 6022985 (2000-02-01), Authelin et al.
patent: 6132771 (2000-10-01), Depui et al.
patent: 6136344 (2000-10-01), Depui et al.
patent: 6183776 (2001-02-01), Depui et al.
patent: 6365184 (2002-04-01), Depui et al.
patent: 6369085 (2002-04-01), Cotton et al.
patent: 6613354 (2003-09-01), Depui et al.
patent: 6677455 (2004-01-01), Kronstrom et al.
patent: 6747155 (2004-06-01), Kronstrom et al.
patent: 7411070 (2008-08-01), Cotton et al.
patent: 7488497 (2009-02-01), Depui et al.
patent: 2005/0075369 (2005-04-01), Cotton et al.
patent: 2007/0122470 (2007-05-01), Johansson et al.
patent: 2009/0297594 (2009-12-01), Depui et al.
patent: 1136564 (1996-11-01), None
patent: 0005129 (1979-10-01), None
patent: 0124495 (1984-11-01), None
patent: 0247983 (1987-12-01), None
patent: 9427988 (1994-12-01), None
patent: 9501977 (1995-01-01), None
patent: 9601623 (1996-01-01), None
patent: 9602535 (1996-02-01), None
Notice of Allegation, filed Nov. 13, 2007, pursuant to thePatented Medicines(Notice of Compliance)Regulationswith respect to Canadian Letters Patent No. 2,290,963.
Haijian Zhu et al. “Influence of water activity in organic solvent + water mixtures on the nature of the crystallizing drug phase. 1 Theophylline”, International Journal of Pharmaceutics 135 (1996) 151-160.
Rajendra K. Khankari et al., “Pharmaceutical hydrates”, Thermochimca Acta 248 (1995) 61-79.
Stephen Byrn et al., “Pharmaceutical Solids: A Strategic Approach to regulatory Consideration”, Pharmaceutical Research, vol. 12, No. 7 (1995), 945-954.
Erlandsson, P. et al., “Resolution of the enantiomers of omeprazole and some of its analogues by liquid chromatography on a trisphenylcarbamoyl cellulose-based stationary phase”, Journal of Chromatography, 532 (1990) 305-319.
von Unge, S. et al. “Stereochemical assignment of the enantiomers of omeprazole from X-ray analysis of a fenchyloxylmethyl derivative of (+)-(R)-omeprazole”,Tetrahedron Asymmetry, vol. 8, No. 12, pp. 1967-1970 (1997).
Japanese Chemical Society, Experimental Chemical Seminar. vol. 18. p. 55 (translation), 1958.
An Introduction to Crystal Chemistry by Evans Cambridge at the Univ. Press, 1964.
Decision of the Pre-grant Opposition filed by Ranbaxy Laboratories Limited against Indian Patent Application No. 1344/DEL/98, Sep. 18, 2007.
Decision of the Pre-grant Opposition filed by Torrent Pharmaceuticals Limited against Indian Patent Application No. 1344/DEL/98, Sep. 18, 2007.
Abstract of CN1136564: Aomeilazole salt hydrate for gastric acid inhibitor and its preparing method, Nov. 27, 2006.

Affiliated with

Also associated with

Rating

Form of S -omeprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Form of S -omeprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Form of S -omeprazole will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183894